ImmunityBio commands a premium valuation on the promise of Anktiva, a chemo-free immunotherapy platform showing early ...

Cohen & Steers REIT & Preferred & Income Fund offers stability amid market volatility, with a 7.6% dividend yield and monthly ...

Q4 2025 revenue fell 26% YoY amid macro headwinds; liquidity supports dividends but upside looks limited. See more here.

The exodus from software stocks over past few weeks was triggered by advancements in agentic AI. Against this backdrop of ...

In this write-up, we review the basics of currency investing and show how FOXY has produced its diversifying returns. Read ...

Davis Real Estate Fund underperformed its benchmark in 2025 as passive inflows dominated the market, increasing the ...

Flowers Foods' robust free cash flow and solid balance sheet underpin intrinsic value. Read why FLO stock remains a Strong ...

After rallying to close 2025, US coal prices held mostly flat in January, restrained by high inventories and low demand in ...

Baidu faces stagnant search MAUs and falling ARPU, betting on AI infrastructure, apps and Kunlunxin IPO for growth. Learn ...

Alexandria’s crumbling share price has been inconsistent with long-term fair value as we calculate it, and today it ...

Alibaba's capex, especially in AI infrastructure, remains elevated and may continue to suppress free cash flow. Read why BABA ...

AI hyperscaler tailwinds, rising margins & EV/Sales undervaluation vs AI infrastructure peers—see why it’s a Buy.